These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 27780425

  • 1. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.
    Hum Vaccin Immunother; 2017 Mar 04; 13(3):533-542. PubMed ID: 27780425
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.
    Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA.
    Hum Vaccin Immunother; 2014 Mar 04; 10(5):1171-80. PubMed ID: 24609063
    [Abstract] [Full Text] [Related]

  • 3. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
    Chit A, Roiz J, Briquet B, Greenberg DP.
    Vaccine; 2015 Jan 29; 33(5):734-41. PubMed ID: 25444791
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
    Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, Spencer S, Fry AM, Flannery B.
    Clin Infect Dis; 2021 Apr 08; 72(7):1147-1157. PubMed ID: 32006430
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults.
    Raviotta JM, Smith KJ, DePasse J, Brown ST, Shim E, Nowalk MP, Zimmerman RK.
    J Am Geriatr Soc; 2016 Oct 08; 64(10):2126-2131. PubMed ID: 27709600
    [Abstract] [Full Text] [Related]

  • 9. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
    Kim YK, Song JY, Jang H, Kim TH, Koo H, Varghese L, Han E.
    Pharmacoeconomics; 2018 Dec 08; 36(12):1475-1490. PubMed ID: 30251078
    [Abstract] [Full Text] [Related]

  • 10. Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review.
    Warmath CR, Ortega-Sanchez IR, Duca LM, Porter RM, Usher MG, Bresee JS, Lafond KE, Davis WW.
    Value Health; 2023 May 08; 26(5):768-779. PubMed ID: 36436790
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
    Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA.
    Clin Infect Dis; 2021 Sep 07; 73(5):816-823. PubMed ID: 33605977
    [Abstract] [Full Text] [Related]

  • 16. Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.
    Sesay S, Brzostek J, Meyer I, Donazzolo Y, Leroux-Roels G, Rouzier R, Astruc B, Szymanski H, Toursarkissian N, Vandermeulen C, Kowalska E, Van Damme P, Salamand C, Pepin S.
    Hum Vaccin Immunother; 2018 Mar 04; 14(3):596-608. PubMed ID: 28968138
    [Abstract] [Full Text] [Related]

  • 17. [Technical guidelines for seasonal influenza vaccination in China, 2019-2020].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov 10; 40(11):1333-1349. PubMed ID: 31838802
    [Abstract] [Full Text] [Related]

  • 18. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, Tsang PH.
    Vaccine; 2015 Feb 25; 33(9):1151-9. PubMed ID: 25613721
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older.
    Greenberg DP, Robertson CA, Talbot HK, Decker MD.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):2058-2064. PubMed ID: 28700265
    [Abstract] [Full Text] [Related]

  • 20. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) Influenza Vaccination TWG.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct 10; 41(10):1555-1576. PubMed ID: 33297613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.